Daniel J. Curran

Insider Reports History

Location
Waltham, MA
Signature
/s/ Shelly Pinto, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel J. Curran:

Company Role Class Num Shares Value Price $ Report Date Ownership
CATALYST PHARMACEUTICALS, INC. Director Common Stock, par value $0.001 per share 0 $0 $21.70 01 Aug 2025 Direct
CATALYST PHARMACEUTICALS, INC. Director Restricted Stock Units 63,583 20 Nov 2025 Direct
CATALYST PHARMACEUTICALS, INC. Director Options to purchase common stock 58,115 20 Nov 2025 Direct
Xilio Therapeutics, Inc. Director Stock Option (right to buy) 31,000 11 Jun 2025 Direct
ALX ONCOLOGY HOLDINGS INC Director Stock Option (right to buy) 16,833 20 Jan 2026 Direct

Insider Reports Filed by Daniel J. Curran

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALXO ALX ONCOLOGY HOLDINGS INC 20 Jan 2026 1 $0 4 Director 21 Jan 2026, 16:30
CPRX CATALYST PHARMACEUTICALS, INC. 20 Nov 2025 2 $0 4 Director 24 Nov 2025, 20:08
ALXO ALX ONCOLOGY HOLDINGS INC 12 Aug 2025 1 $0 4 Director 13 Aug 2025, 16:47
ALXO ALX ONCOLOGY HOLDINGS INC 12 Aug 2025 0 $0 3 Director 13 Aug 2025, 16:19
CPRX CATALYST PHARMACEUTICALS, INC. 01 Aug 2025 0 $0 3 Director 08 Aug 2025, 17:00
XLO Xilio Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:36
XLO Xilio Therapeutics, Inc. 14 Jun 2024 1 $0 4 Director 17 Jun 2024, 16:30
XLO Xilio Therapeutics, Inc. 21 Oct 2021 0 $0 3 Director 21 Oct 2021, 20:46